File size: 59,163 Bytes
0ea9615 | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 | # PolyGuard OpenEnv: Training Medication-Safety Agents Inside a Verifier-Backed World
Someone does not experience an unsafe medication regimen as "polypharmacy."
They experience it as dizziness after a new sleep medication, bleeding after a
painkiller is added to a blood thinner, confusion from a sedative-opioid
combination, or a preventable emergency visit because five prescribers each saw
one slice of the medication list.
The dangerous part is often not a single drug. It is the combination: the wrong
pair, the wrong dose in the wrong organ-function context, the missing lab, the
duplicated class, the abrupt stop that should have been a taper, or the model
that confidently says "looks fine" because it was never forced to act inside a
safety-checked environment.
That is the problem PolyGuard was built for.
The [CDC medication-safety data page](https://www.cdc.gov/medication-safety/data-research/facts-stats/index.html)
reports that adverse drug events send more than 1.5 million people to emergency
departments in the United States every year, with almost 500,000
hospitalizations. Adults 65 and older account for more than 600,000 of those
visits. A CDC-authored [JAMA surveillance study](https://jamanetwork.com/journals/jama/fullarticle/2585977)
found that older adults made up 34.5 percent of outpatient adverse-drug-event
ED visits and had the highest hospitalization rate, 43.6 percent. Globally, the
[WHO Medication Without Harm challenge](https://www.who.int/initiatives/medication-without-harm)
estimates the cost associated with medication errors at USD 42 billion
annually. AHRQ's deprescribing safety review summarizes estimates that
[45 percent of older adults are exposed to polypharmacy and 58 percent to
potentially inappropriate medications](https://www.ncbi.nlm.nih.gov/books/NBK600387/).
Not every adverse drug event is caused by an incorrect drug combination. But
these numbers describe the harm surface PolyGuard targets: medication decisions
where combination risk, monitoring gaps, frailty, organ function, uncertainty,
and action sequencing all matter at once.
PolyGuard turns that problem into an OpenEnv-compatible reinforcement-learning
environment for polypharmacy safety, medication optimization, deprescribing,
safe substitution, missing-evidence recovery, and precision dosing. A language
model policy observes a constrained patient/regimen state, chooses one legal
candidate action, receives verifier-backed reward, and improves through SFT
plus GRPO-style post-training.
It is not medical software and it is not clinical advice. It is a controlled
research environment for studying how language-model policies can be trained,
audited, and stress-tested on safety-critical medication action selection.
## What To Open First
- GitHub repository:
[Vishwa-docs/Meta_Pytorch_OpenEnv_Scaler_VK](https://github.com/Vishwa-docs/Meta_Pytorch_OpenEnv_Scaler_VK)
- Live product Space:
[TheJackBright/polyguard-openenv-workbench](https://huggingface.co/spaces/TheJackBright/polyguard-openenv-workbench)
- One-run Colab/HF notebook:
[PolyGuard_SFT_GRPO_One_Run_Runner.ipynb](https://colab.research.google.com/github/Vishwa-docs/Meta_Pytorch_OpenEnv_Scaler_VK/blob/master/polyguard-rl/PolyGuard_SFT_GRPO_One_Run_Runner.ipynb)
- Final evidence index:
[polyguard-rl/docs/results/final_submission_evidence/README.md](polyguard-rl/docs/results/final_submission_evidence/README.md)
- Artifact and traceability guide:
[polyguard-rl/docs/submission_artifacts.md](polyguard-rl/docs/submission_artifacts.md)
- Final artifact/evidence Space:
[adithya9903/polyguard-openenv-final-artifacts](https://huggingface.co/spaces/adithya9903/polyguard-openenv-final-artifacts)
The final artifact/evidence Space hosts the Qwen 3B artifact bundle. The Qwen
0.5B and 1.5B runs were trained using a second Hugging Face account, so their
model artifacts could not be hosted in the same final Space. Their report
mirrors are checked into this repo:
[0.5B reports](polyguard-rl/docs/results/submission_evidence_qwen_0_5b_1_5b_3b/reports/runs/qwen-qwen2-5-0-5b-instruct)
and
[1.5B reports](polyguard-rl/docs/results/submission_evidence_qwen_0_5b_1_5b_3b/reports/runs/qwen-qwen2-5-1-5b-instruct).
## The Research Bet
Medication safety is combinatorial, partially observable, and high stakes. A
useful policy has to do more than generate a plausible answer. It has to notice
drug-drug interaction risk, reason about comorbidities and organ function,
respect taper and monitoring requirements, choose safe substitutions, abstain
or ask for review when uncertainty is high, and expose why it acted.
The machine-learning pressure is just as real. If a medication vocabulary has
500 drugs, the number of possible five-drug combinations is:
```text
C(500, 5) = 255,244,687,600
```
Exhaustive search is not a serious option. The paper that inspired this
project, [Neural Bandits for Data Mining: Searching for Dangerous Polypharmacy](https://arxiv.org/abs/2212.05190),
frames dangerous polypharmacy discovery as a bandit search problem over a huge
combination space. It benchmarks neural bandit search over simulated
polypharmacy datasets with 500 drugs and 100,000 distinct combinations, and
reports detection of up to 72 percent of potentially inappropriate
polypharmacies with 99 percent average precision after 30,000 time steps.
PolyGuard borrows that search instinct, then moves the problem from offline
combination mining into an agentic environment. The policy sees a patient
state, chooses among legal clinical action candidates, and is judged by a
deterministic verifier and reward router rather than by free-form text
preference alone.
The research question is narrow and concrete:
Can environment-backed feedback make a small open model better at safe
medication action selection than prompt-only, first-legal, rule-only, or
single-agent baselines?
The answer in this repository is an inspectable system:
1. A finite-horizon OpenEnv simulation for medication decisions.
2. A constrained action space, so the model chooses candidate actions instead
of inventing arbitrary clinical instructions.
3. A legality verifier that prevents unsafe state mutation.
4. Thirteen reward components rolled into four primary reward channels.
5. A multi-agent policy stack with supervisor routing, contextual bandit
reranking, planner selection, critic veto, and explanation logging.
6. SFT for format and clinical-prior warm start.
7. GRPO with environment-backed reward, not an opaque LLM judge.
8. Agentic evaluation with baseline comparison, policy ablations, post-save
inference, robustness checks, action traces, and failure mining.

## A Failure Trace That Motivated the Design
In the final matched-seed traces, the failure mode is not abstract. On seeds
`8000` and `8004`, the basic prompt-style proxy repeatedly chose `cand_01`,
the first legal candidate. In those cases, `cand_01` meant `KEEP_REGIMEN` while
a hidden `warfarin_like` + `nsaid_like` interaction remained unresolved. The
verifier recorded `holdout_ddi_not_addressed`.
The full PolyGuard pipeline selected `cand_03`, a safer intervention candidate,
and avoided those failure reasons.
That is the core argument of the project: medication AI should be judged inside
a stateful safety environment, not only by whether its answer sounds clinically
plausible.
Internal evidence:
[basic_llm_vs_polyguard_report.json](polyguard-rl/docs/results/final_submission_evidence/reports/basic_llm_vs_polyguard_report.json)
and
[action_traces.jsonl](polyguard-rl/docs/results/final_submission_evidence/reports/action_traces.jsonl).
## Safety Contract
PolyGuard does not let a model directly mutate a medication list from free
text. Every decision is candidate-based, verifier-checked, reward-decomposed,
and traced. Illegal actions can be scored, penalized, and logged, but they do
not change patient state.
The repo evidence for this contract is spread across the environment, rules,
and final reports:
| Claim | Repo evidence |
| --- | --- |
| Hard contraindication examples are represented | [app/knowledge/ddi_knowledge.py](polyguard-rl/app/knowledge/ddi_knowledge.py) |
| Safer alternatives are explicit | [app/knowledge/substitution_rules.py](polyguard-rl/app/knowledge/substitution_rules.py) |
| Unsafe substitutions and dose escalations are blocked before state mutation | [app/env/verifier.py](polyguard-rl/app/env/verifier.py) |
| Reward hacking and loop-like behavior are surfaced | [app/env/anti_cheat.py](polyguard-rl/app/env/anti_cheat.py), [docs/reward_design.md](polyguard-rl/docs/reward_design.md) |
| Baseline failure is traceable by seed and candidate | [basic_llm_vs_polyguard_report.json](polyguard-rl/docs/results/final_submission_evidence/reports/basic_llm_vs_polyguard_report.json), [action_traces.jsonl](polyguard-rl/docs/results/final_submission_evidence/reports/action_traces.jsonl) |
| Final claims are separated from older smoke artifacts | [final_submission_evidence/README.md](polyguard-rl/docs/results/final_submission_evidence/README.md) |
## Project Map
The implementation lives under [polyguard-rl/](polyguard-rl/).
| Area | Key paths |
| --- | --- |
| OpenEnv runtime | [openenv.yaml](polyguard-rl/openenv.yaml), [app/env/env_core.py](polyguard-rl/app/env/env_core.py), [app/env/fastapi_app.py](polyguard-rl/app/env/fastapi_app.py), [server/app.py](polyguard-rl/server/app.py) |
| Action/state contracts | [app/common/types.py](polyguard-rl/app/common/types.py), [app/common/enums.py](polyguard-rl/app/common/enums.py) |
| Candidate generation and verifier | [app/models/policy/candidate_builder.py](polyguard-rl/app/models/policy/candidate_builder.py), [app/env/verifier.py](polyguard-rl/app/env/verifier.py) |
| Reward and anti-cheat | [app/env/reward_router.py](polyguard-rl/app/env/reward_router.py), [app/env/reward_scaling.py](polyguard-rl/app/env/reward_scaling.py), [app/env/anti_cheat.py](polyguard-rl/app/env/anti_cheat.py), [configs/rewards.yaml](polyguard-rl/configs/rewards.yaml) |
| Multi-agent policy | [app/agents/](polyguard-rl/app/agents/), [docs/agents.md](polyguard-rl/docs/agents.md) |
| Bandits and baselines | [app/models/baselines/contextual_bandit.py](polyguard-rl/app/models/baselines/contextual_bandit.py), [app/models/baselines/contextual_bandit_policy.py](polyguard-rl/app/models/baselines/contextual_bandit_policy.py), [app/models/baselines/](polyguard-rl/app/models/baselines/) |
| Training | [app/training/](polyguard-rl/app/training/), [scripts/train_sft_trl.py](polyguard-rl/scripts/train_sft_trl.py), [scripts/train_grpo_trl.py](polyguard-rl/scripts/train_grpo_trl.py), [docs/training.md](polyguard-rl/docs/training.md) |
| Data | [data/raw/knowledge/drug_knowledge.json](polyguard-rl/data/raw/knowledge/drug_knowledge.json), [data/scenarios/](polyguard-rl/data/scenarios/), [docs/datasets.md](polyguard-rl/docs/datasets.md) |
| Evaluation | [app/evaluation/](polyguard-rl/app/evaluation/), [scripts/evaluate_all.py](polyguard-rl/scripts/evaluate_all.py), [docs/evaluation.md](polyguard-rl/docs/evaluation.md) |
| Product API/UI | [app/api/](polyguard-rl/app/api/), [app/ui/frontend/](polyguard-rl/app/ui/frontend/), [docs/ui.md](polyguard-rl/docs/ui.md) |
| Math | [docs/math.md](polyguard-rl/docs/math.md), [docs/mathematics.md](polyguard-rl/docs/mathematics.md) |
| Results | [docs/results/final_submission_evidence/](polyguard-rl/docs/results/final_submission_evidence/) |
Supporting docs include [architecture.md](polyguard-rl/docs/architecture.md),
[environment_design.md](polyguard-rl/docs/environment_design.md),
[reward_design.md](polyguard-rl/docs/reward_design.md),
[safety.md](polyguard-rl/docs/safety.md),
[precision_dosing.md](polyguard-rl/docs/precision_dosing.md),
[graph_models.md](polyguard-rl/docs/graph_models.md),
[ablations.md](polyguard-rl/docs/ablations.md),
[api.md](polyguard-rl/docs/api.md),
[deployment.md](polyguard-rl/docs/deployment.md),
[ui.md](polyguard-rl/docs/ui.md),
[DEMO_RECORDING_SCRIPT.md](polyguard-rl/docs/DEMO_RECORDING_SCRIPT.md), and
[submission_artifacts.md](polyguard-rl/docs/submission_artifacts.md).
## The OpenEnv Environment
At the center is `PolyGuardEnv`, implemented in
[app/env/env_core.py](polyguard-rl/app/env/env_core.py). It follows the
OpenEnv/Gym shape:
```text
reset(seed, difficulty, sub_environment, scenario_id, patient_id)
-> PolyGuardObservation
step(PolyGuardAction)
-> (PolyGuardObservation, reward, done, info)
```
At reset, the environment loads or generates a patient scenario, selects a
difficulty and sub-environment, computes a risk summary, builds candidate
actions, estimates uncertainty, and emits a strict observation. At step time,
the environment parses the action, checks legality, evaluates anti-cheat rules,
mutates state only if the action is safe, computes decomposed reward, appends a
trace, and returns detailed `info` fields such as failure reasons, transition
delta, primary reward channels, invalid-action count, and timeout checks.

PolyGuard is not one task. It cycles through specialized sub-environments:
| Sub-environment | What it stresses |
| --- | --- |
| `DDI` | High-risk drug-drug interaction recognition and resolution |
| `BANDIT_MINING` | Candidate exploration and shortlist/ranking behavior inspired by bandit search |
| `REGIMEN_RISK` | General medication burden and regimen optimization |
| `PRECISION_DOSING` | Dose-hold, dose reduction, renal/hepatic guardrails, monitoring decisions |
| `LONGITUDINAL_DEPRESCRIBING` | Multi-step taper/deprescribing behavior over a longer horizon |
| `WEB_SEARCH_MISSING_DATA` | Evidence fetch or review when critical data is missing |
| `ALTERNATIVE_SUGGESTION` | Safe alternatives and within-class substitution |
| `NEW_DRUG_DECOMPOSITION` | First-pass reasoning over an unknown or combination medication |
The curriculum in [app/env/curriculum.py](polyguard-rl/app/env/curriculum.py)
starts with short easy DDI/regimen-risk episodes, then adds bandit and
alternative-selection tasks, and finally hard cases with precision dosing,
longitudinal deprescribing, missing data, and new-drug decomposition.
### State and Observation
The latent state is represented by `PolyGuardState` and includes patient
demographics, active decision mode, step budget, medications, dose buckets,
comorbidities, labs, vitals, frailty, adherence, monitoring gaps, prior adverse
event history, burden score, severe-pair count, precision dosing flags,
unresolved conflicts, action history, cumulative reward, and done state.
The agent does not get every simulator internal. It receives a controlled
`PolyGuardObservation` with a patient summary, medication table, comorbidity
summary, organ function, labs/vitals, graph safety summary, burden summary,
precision dosing flags, unresolved conflicts, candidate actions, step budget,
action history, warnings, abstention indicators, seed, scenario, difficulty,
and sub-environment.
This split matters. PolyGuard is a partially observable environment. Missing
labs and unresolved conflicts are visible as uncertainty signals, not as hidden
reward traps.
## Action Space and Safety Constraints
PolyGuard deliberately avoids unconstrained text actions. The policy chooses a
strict `PolyGuardAction` with fields such as `mode`, `action_type`,
`target_drug`, `replacement_drug`, `dose_bucket`, `taper_days`,
`monitoring_plan`, `evidence_query`, `new_drug_name`, `candidate_components`,
`candidate_id`, `confidence`, and `rationale_brief`.
The action types are compact:
| Family | Action types |
| --- | --- |
| Regimen | `KEEP_REGIMEN`, `STOP_DRUG`, `SUBSTITUTE_WITHIN_CLASS`, `RECOMMEND_ALTERNATIVE` |
| Dosing | `REDUCE_DOSE_BUCKET`, `INCREASE_DOSE_BUCKET`, `DOSE_HOLD`, `ORDER_MONITORING_AND_WAIT` |
| Deprescribing | `TAPER_INITIATE`, `TAPER_CONTINUE` |
| Evidence and uncertainty | `FETCH_EXTERNAL_EVIDENCE`, `DECOMPOSE_NEW_DRUG`, `REQUEST_SPECIALIST_REVIEW`, `REQUEST_PHARMACIST_REVIEW` |
The candidate builder in
[app/models/policy/candidate_builder.py](polyguard-rl/app/models/policy/candidate_builder.py)
generates a bounded candidate set:
```text
3 <= |C_t| <= 10
```
Each candidate carries estimated safety delta, burden delta, disease stability,
uncertainty score, rationale tags, required monitoring, and a legality
precheck. Policy selection is candidate selection:
```text
a_t = to_action(c_t), where c_t is in C_t
```
The verifier in [app/env/verifier.py](polyguard-rl/app/env/verifier.py)
enforces hard safety constraints before state mutation. It checks that target
drugs exist when required, substitutions and alternatives are allowed, evidence
domains are allowlisted, new-drug decomposition includes required components,
taper-required drugs are not stopped abruptly, renal/hepatic unsafe dose
escalation is blocked, duplicate therapy and contraindicated replacement pairs
are blocked, and monitoring/hold actions include a monitoring plan.
Illegal actions can receive reward penalties and become visible in traces, but
they do not mutate patient state.
## Multi-Agent Policy Stack
The "agents" in PolyGuard are an auditable policy factorization rather than
free-form independent chatbots. A step flows through:
```text
MedRec -> Evidence -> GraphSafety -> Dosing -> Candidate
-> Supervisor -> Planner -> Critic -> Env -> Explainer
```

| Agent/module | Role |
| --- | --- |
| `MedRecAgent` | Summarizes current regimen and medication burden |
| `EvidenceAgent` | Retrieves local or fallback evidence when missing data is present |
| `GraphSafetyAgent` | Scores risky pairs, side-effect load, duplicate therapy, and graph safety patterns |
| `DosingAgent` | Detects dose-sensitive cases and dose-hold opportunities |
| `CandidateAgent` | Exposes legal candidate actions from the environment candidate builder |
| `SupervisorAgent` | Routes to regimen optimization, dose optimization, or review mode |
| `PlannerAgent` | Selects an action from candidates through the policy provider |
| `CriticAgent` | Vetoes illegal or unsafe proposed actions and can force review fallback |
| `ExplainerAgent` | Records grounded rationale for demo, replay, and audit |
The orchestration modes are `sequential_pipeline`, `supervisor_routed`,
`replan_on_veto`, and `lightweight_debate`. Policy-stack ablations compare
`bandit-only`, `llm-only`, and `llm+bandit`.
## Contextual Bandits
PolyGuard uses contextual bandits as an inspectable candidate-reranking layer.
This is where the project most directly echoes the arXiv bandit inspiration:
unsafe polypharmacy search is combinatorial, so the system should learn which
regions of the candidate/action space are worth exploring rather than enumerate
everything.
Each candidate becomes an 8-dimensional feature vector:
```text
x(c) = [
1,
I[legality_precheck],
estimated_safety_delta,
burden_delta,
disease_stability_estimate,
1 - uncertainty_score,
I[mode = DOSE_OPT],
I[mode = REVIEW]
]
```
An arm is keyed by macro mode and action type:
```text
arm(c) = mode(c) || ":" || action_type(c)
```
The LinUCB variant maintains, for each arm `a`:
```text
A_a = I + sum x x^T
b_a = sum r x
theta_a = A_a^{-1} b_a
score_a(x) = theta_a^T x + alpha * sqrt(x^T A_a^{-1} x)
```
There is also a Thompson-style variant:
```text
score_a(x) = theta_a^T x + Normal(0, alpha)
```
This layer can shortlist candidates before the planner emits the final action.
It is deliberately kept inside the candidate space: the bandit can improve
ordering and exploration, but it cannot invent an unsafe action outside the
environment contract.
## Reward Model
The reward model is decomposed on purpose. A single scalar reward is needed for
RL, but safety-critical RL needs more than one opaque number. PolyGuard logs 13
component columns and four primary channels on every step.

All reward values are clamped and quantized:
```text
q(x) = round(clip(x, 0.001, 0.999), 3)
```
The 13 reward components are:
| Component | Weight | Meaning |
| --- | ---: | --- |
| `format_compliance_score` | 0.08 | Action payload conforms to the schema |
| `candidate_alignment_score` | 0.08 | The model selected a valid candidate-style id |
| `legality_score` | 0.12 | The verifier accepted the action |
| `safety_delta_score` | 0.15 | Severe-pair and burden risk decreased |
| `burden_improvement_score` | 0.08 | Dose-weighted medication burden improved |
| `disease_stability_score` | 0.10 | The action did not destabilize underlying disease management |
| `dosing_quality_score` | 0.08 | Dose-sensitive routing/action quality |
| `abstention_quality_score` | 0.06 | Review/abstention is appropriate under uncertainty |
| `efficiency_score` | 0.06 | The action uses the finite step budget well |
| `process_fidelity_score` | 0.06 | The action follows task-specific process expectations |
| `explanation_grounding_score` | 0.03 | The rationale is present and grounded |
| `anti_cheat_score` | 0.06 | Reward-hacking checks did not fire |
| `uncertainty_calibration_score` | 0.04 | Confidence matches observable uncertainty |
The scalar reward is a weighted average:
```text
R_env(s_t, a_t, s_{t+1}) = q( sum_i w_i c_i / sum_i w_i )
```
Safety-heavy terms dominate the total weight:
```text
legality + safety_delta + burden + disease_stability + anti_cheat
= 0.12 + 0.15 + 0.08 + 0.10 + 0.06
= 0.51
```
The four primary reward channels are:
| Channel | Component family |
| --- | --- |
| `safety_legality` | legality, candidate alignment, anti-cheat, uncertainty calibration |
| `clinical_improvement` | safety delta, burden improvement, disease stability |
| `dosing_quality` | dosing quality and abstention quality |
| `process_integrity` | format compliance, efficiency, process fidelity, explanation grounding |
These channels are emitted in `info.primary_reward_channels`, GRPO reward logs,
reports, plots, and ablation summaries.
## Anti-Cheat and Failure Visibility
RL policies exploit reward functions. PolyGuard makes common shortcut failures
explicit: repeated action loops, excessive keep-regimen behavior, excessive
review/abstention behavior, candidate ID mismatch, candidate outside the legal
set, hidden high-risk DDI no-op behavior, parser exploit patterns in rationales,
and retries of failed no-op actions.
If an exploit is detected:
```text
anti_cheat_score = 0.001
done = true
termination_reason = "exploit_detection"
```
Episodes can also terminate on step budget exhaustion, repeated invalid
actions, safety-veto threshold, patient destabilization, safe resolution,
wall-clock timeout, or per-step timeout.

## Mathematics
PolyGuard can be read as a finite-horizon constrained partially observable
Markov decision process:
```text
M = (S, A, O, T, R, H, C)
```
where `S` is latent patient/regimen state, `A` is the constrained medication
action set, `O` is the controlled observation, `T(s' | s, a)` is the transition
function, `R(s, a, s')` is verifier-backed reward, `H` is the episode horizon,
and `C(s, a)` is the hard safety/legality constraint predicate.
The objective is:
```text
maximize_pi E_pi [ sum_{t=0}^{H-1} R(s_t, a_t, s_{t+1}) ]
subject to C(s_t, a_t) = 1 whenever possible
```
There is no explicit discount factor in the runtime. Time preference enters
through finite horizons and the efficiency reward:
```text
efficiency_t = q(1 - step_count_t / (max_steps + 1))
```
State transition is two-gated:
```text
if verifier(s_t, a_t).legal and not anti_cheat(s_t, a_t):
s_{t+1} = T(s_t, a_t)
else:
s_{t+1} = rollback_state_with_failed_action_record(s_t, a_t)
```
Risk-like deltas become reward through:
```text
delta_reward(pre, post) = q(0.5 + 0.6 * (pre - post))
```
For burden and contraindicated-pair improvement:
```text
burden_reward = delta_reward(pre_burden, post_burden)
pair_reward = delta_reward(pre_pairs, post_pairs)
safety_delta_score =
q(0.65 * pair_reward + 0.35 * burden_reward) if legal
0.001 otherwise
```
GRPO uses environment execution as the reward function. For each prompt, the
model emits candidate completions; PolyGuard parses the candidate id, resets a
deterministic environment using the recorded seed and scenario fields, executes
one step, and returns reward. The training reward combines environment reward
with a legality bonus:
```text
legal_bonus = 0.95 if action is legal else 0.05
R_GRPO = q(0.80 * R_env + 0.20 * legal_bonus)
```
Conceptually, GRPO forms a within-prompt advantage:
```text
A_i = (R_i - mean_j R_j) / (std_j R_j + epsilon)
```
and optimizes a clipped policy-ratio objective with KL regularization. The
optimizer mechanics are TRL's; PolyGuard's contribution is the verifier-backed
reward function and the controlled action/state environment. The expanded
derivation is in
[polyguard-rl/docs/mathematics.md](polyguard-rl/docs/mathematics.md).
## Data and Dataset Pipeline
The data pipeline builds a compact medication-safety substrate from local drug
knowledge, synthetic patients, scenario files, retrieval text, and optional
external augmentation.

The dataset design is documented in
[docs/datasets.md](polyguard-rl/docs/datasets.md). The local generated
pipeline produces these processed artifacts and counts:
| Artifact | Count | Path |
| --- | ---: | --- |
| Normalized drug rows | 10 | `data/processed/normalized_drugs.parquet` |
| Drug class rows | 10 | `data/processed/drug_classes.parquet` |
| Interaction rows | 2 | `data/processed/interactions.parquet` |
| Graph edges | 18 | `data/processed/graph_edges.parquet` |
| Synthetic patients | 20 | `data/processed/patients_synthetic.parquet` |
| Retrieval documents | 8 | `data/processed/retrieval_corpus.jsonl` |
| Easy scenarios | 100 | [data/scenarios/easy/](polyguard-rl/data/scenarios/easy/) |
| Medium scenarios | 200 | [data/scenarios/medium/](polyguard-rl/data/scenarios/medium/) |
| Hard scenarios | 200 | [data/scenarios/hard/](polyguard-rl/data/scenarios/hard/) |
| Local small SFT rows | 80 | `data/processed/training_corpus_sft.jsonl` |
| Local small GRPO prompts | 80 | `data/processed/training_corpus_grpo_prompts.jsonl` |
The provenance manifest generated by the local pipeline records source policy
and counts at `data/processed/provenance_manifest.json`.
Additional data-governance and rule artifacts are produced or consumed by the
pipeline:
| Artifact | Why it matters |
| --- | --- |
| `data/processed/ingested_sources.json` | Source ingestion ledger used by the local build |
| `data/processed/feature_dictionary.json` | Names and meanings of structured model features |
| `data/processed/burden_rules.yaml` | Medication-burden and duplicate-therapy rules |
| `data/processed/substitution_rules.yaml` | Data-level safer-substitution rules |
| `data/processed/taper_rules.yaml` | Deprescribing and taper requirements |
| `data/retrieval_index/index.json` | Retrieval index over local evidence chunks |
The local knowledge seed is
[data/raw/knowledge/drug_knowledge.json](polyguard-rl/data/raw/knowledge/drug_knowledge.json).
It contains drug classes, example high-risk pairs, renal and hepatic flags,
side-effect tags, substitution rules, and taper requirements. The processed
tables then feed graph modeling, candidate generation, environment scenarios,
retrieval, SFT rows, and GRPO prompts.
The full training/evidence runs used 2,000 examples per Qwen model, recorded in
the final reports under
[docs/results/final_submission_evidence/reports/](polyguard-rl/docs/results/final_submission_evidence/reports/).
## Models Inside the Environment
PolyGuard combines learned and rule-backed components:
- Graph safety model:
[app/models/graph/](polyguard-rl/app/models/graph/) produces regimen
embeddings, pairwise DDI severity, severe-alert probability, and side-effect
tag probabilities.
- Tabular risk model:
[app/models/tabular/](polyguard-rl/app/models/tabular/) supports calibrated
patient/regimen risk heads and evaluation.
- Dosing model:
[app/models/dosing/](polyguard-rl/app/models/dosing/) models dose-sensitive
states with target attainment, toxicity, underdose risk, organ stress,
interaction load, and monitoring need.
- Retrieval:
[app/models/retrieval/](polyguard-rl/app/models/retrieval/) and
[app/knowledge/](polyguard-rl/app/knowledge/) provide local evidence chunks,
drug rules, renal/hepatic guardrails, duplicate therapy rules, substitution
rules, taper rules, burden scoring, and side-effect ontology.
- Active model runtime:
[app/models/policy/active_model.py](polyguard-rl/app/models/policy/active_model.py)
discovers activated artifacts from `checkpoints/active/active_model_manifest.json`;
the tracked evidence mirror includes
[docs/results/active_model_manifest.json](polyguard-rl/docs/results/active_model_manifest.json).
The provider load order prefers a GRPO adapter, then merged model, then SFT
adapter.
- Provider runtime:
[app/models/policy/provider_runtime.py](polyguard-rl/app/models/policy/provider_runtime.py)
is Transformers-first, with optional Ollama when enabled. If model loading is
unavailable, the runtime falls back to deterministic safety ranking.
Tracked support-model reports show that the environment is not only an LLM
wrapper:
| Component | Report | Current tracked result |
| --- | --- | --- |
| Graph model | [docs/results/graph_train.json](polyguard-rl/docs/results/graph_train.json) | `status: trained`, `num_samples: 180`, artifact path `outputs/models/graph_model.pkl` |
| Tabular risk model | [docs/results/risk_train.json](polyguard-rl/docs/results/risk_train.json) | `status: trained`, `dataset_size: 180`, `train_mae: 0.0033`, artifact path `outputs/models/tabular_risk.pkl` |
| Dose surrogate model | [docs/results/dose_train.json](polyguard-rl/docs/results/dose_train.json) | `status: trained`, `dataset_size: 120`, `train_mae: 0.0025`, artifact path `outputs/models/dose_model.pkl` |
The hard-coded contraindicated seed pairs in
[app/knowledge/ddi_knowledge.py](polyguard-rl/app/knowledge/ddi_knowledge.py)
include `warfarin_like` + `nsaid_like` and `benzodiazepine_like` +
`opioid_like`. Substitution rules in
[app/knowledge/substitution_rules.py](polyguard-rl/app/knowledge/substitution_rules.py)
include safer alternatives such as `nsaid_like -> acetaminophen_like`,
`nsaid_like -> topical_nsaid_like`, `benzodiazepine_like ->
non_benzo_sleep_support`, and `opioid_like -> non_opioid_analgesic`.
### Precision Dosing
Precision dosing uses sensitive classes such as anticoagulants, sedatives, and
glucose-lowering drugs. The dosing agent and surrogate model are implemented in
[app/agents/dosing_agent.py](polyguard-rl/app/agents/dosing_agent.py) and
[app/models/dosing/](polyguard-rl/app/models/dosing/).
The surrogate PK/PD transition in
[app/models/dosing/surrogate_pkpd.py](polyguard-rl/app/models/dosing/surrogate_pkpd.py)
uses effect, toxicity, underdose, organ stress, and interaction load:
```text
effective_delta = dose_delta * (1 - min(0.6, organ_factor * 0.4))
effect' =
clip(effect + 0.28 * effective_delta - 0.05 * interaction_factor, 0, 1)
toxicity_gain =
max(0, dose_delta) * (0.35 + 0.25 * organ_factor + 0.20 * interaction_factor)
toxicity' =
clip(0.85 * toxicity + toxicity_gain, 0, 1)
underdose' =
clip(1 - effect' + 0.15 * max(0, -dose_delta), 0, 1)
```
The higher-level dosing metrics use target attainment, toxicity avoidance,
underdose risk, and monitoring need:
```text
target_attainment = 1 - abs(effect_level - 0.62)
toxicity_proxy = toxicity_level + 0.20 * organ_stress + 0.12 * interaction_load
measurement_need = max(toxicity_proxy, underdose_proxy)
```
## Training and Post-Training
The training stack is deliberately staged:
1. Build structured data, scenarios, retrieval records, SFT examples, and GRPO
prompts.
2. Run SFT with TRL to teach the model the candidate-id format and obvious
clinical priors.
3. Run GRPO with environment-backed reward, where sampled candidate completions
are executed in PolyGuardEnv and scored by the verifier/reward router.
4. Track sampled generations, reward components, primary reward channels,
legality, anti-cheat events, and training curves.
5. Run policy-stack ablations and baseline comparisons.
6. Merge or export adapters safely.
7. Validate post-save inference from the saved artifact, not from an in-memory
training object.
8. Generate reports, charts, action traces, and final artifact manifests.
The relevant training source files are
[scripts/train_sft_trl.py](polyguard-rl/scripts/train_sft_trl.py),
[scripts/train_grpo_trl.py](polyguard-rl/scripts/train_grpo_trl.py),
[app/training/sft_trl.py](polyguard-rl/app/training/sft_trl.py),
[app/training/grpo_trl.py](polyguard-rl/app/training/grpo_trl.py),
[app/training/reward_functions.py](polyguard-rl/app/training/reward_functions.py),
[app/training/openenv_wrapper.py](polyguard-rl/app/training/openenv_wrapper.py),
and [app/hf_space/training_runner.py](polyguard-rl/app/hf_space/training_runner.py).
The one-run notebook is
[polyguard-rl/PolyGuard_SFT_GRPO_One_Run_Runner.ipynb](polyguard-rl/PolyGuard_SFT_GRPO_One_Run_Runner.ipynb).
It is the accessible Colab/HF workflow for building data, running checks,
launching training, pulling reports, generating charts, validating inference,
activating a model, deploying the product Space, and running acceptance checks.
The modular notebook series is:
- [01_data_building.ipynb](polyguard-rl/notebooks/01_data_building.ipynb)
- [02_knowledge_graph.ipynb](polyguard-rl/notebooks/02_knowledge_graph.ipynb)
- [03_risk_models.ipynb](polyguard-rl/notebooks/03_risk_models.ipynb)
- [04_environment_validation.ipynb](polyguard-rl/notebooks/04_environment_validation.ipynb)
- [05_sft_debug.ipynb](polyguard-rl/notebooks/05_sft_debug.ipynb)
- [06_grpo_debug.ipynb](polyguard-rl/notebooks/06_grpo_debug.ipynb)
- [07_policy_analysis.ipynb](polyguard-rl/notebooks/07_policy_analysis.ipynb)
- [08_dosing_analysis.ipynb](polyguard-rl/notebooks/08_dosing_analysis.ipynb)
- [09_training_loop.ipynb](polyguard-rl/notebooks/09_training_loop.ipynb)
For exact local and remote execution details, use
[docs/training.md](polyguard-rl/docs/training.md) and
[docs/submission_artifacts.md](polyguard-rl/docs/submission_artifacts.md).
This blog focuses on architecture, data, evaluation, and evidence rather than
private or environment-specific commands.
## Training Curves and Model Results
The final curated evidence lives in
[polyguard-rl/docs/results/final_submission_evidence/](polyguard-rl/docs/results/final_submission_evidence/).
It replaces earlier smoke-run charts and older 0.5B/1.5B-only views.
### SFT Loss Across Qwen Runs

The SFT curves, post-save valid rates, and token-accuracy histories show that
the models learned the candidate-id output contract rather than only producing
unconstrained prose. The visible curves drop from roughly `3.0-3.6` initial
loss to low final loss across all three Qwen sizes.

The tracked per-model summaries are:
| Run | Model | Epochs | Final step | Runtime | Key SFT metrics |
| --- | --- | ---: | ---: | ---: | --- |
| `qwen-qwen2-5-0-5b-instruct` | `Qwen/Qwen2.5-0.5B-Instruct` | 2 | 2,000 | `234.6302s` | loss `3.0856 -> 0.0626`, best `0.0057`, train loss `0.1923`, token accuracy `0.9717`, valid rate `1.0`, avg env reward `0.726`, latency `1.839s` |
| `qwen-qwen2-5-1-5b-instruct` | `Qwen/Qwen2.5-1.5B-Instruct` | 2 | 4,000 | `483.7085s` | loss `2.9686 -> 0.0681`, best `0.0009`, train loss `0.1152`, token accuracy `0.9726`, valid rate `1.0`, avg env reward `0.726`, latency `2.158s` |
| `qwen-qwen2-5-3b-instruct` | `Qwen/Qwen2.5-3B-Instruct` | 2 | 2,000 | `715.2908s` | loss `3.5687 -> 0.054`, best `0.0022`, train loss `0.1569`, token accuracy `0.9750`, SFT avg env reward `0.781`, SFT latency `2.863s` |
Each SFT run used 2,000 examples. The 0.5B and 3B runs recorded 2,001 history
rows including the final trainer summary; the 1.5B run recorded 4,001 history
rows because its batch configuration produced 4,000 final steps.
### GRPO Reward Curve


The complete GRPO evidence is available for Qwen 3B:
- Backend: `trl_transformers`
- Model: `Qwen/Qwen2.5-3B-Instruct`
- Records: `2000`
- Epochs: `1.0`
- Final step: `2000`
- Runtime: `6873.9375s` (`1.91h`)
- Reward samples: `4000`
- GRPO average reward: `0.767`
- GRPO reward history: min `0.376`, max `0.880`, last `0.812`, average `0.76685`
- GRPO train loss: `0.000002665`
- Post-save GRPO valid rate: `1.0`
- Post-save GRPO average environment reward: `0.726`
- Post-save GRPO average latency: `3.681s`
- Artifact path recorded in the report: `checkpoints/sweeps/qwen-qwen2-5-3b-instruct/grpo_adapter`
Source reports:
[grpo_trl_run.json](polyguard-rl/docs/results/final_submission_evidence/reports/grpo_trl_run.json),
[postsave_inference_grpo.json](polyguard-rl/docs/results/final_submission_evidence/reports/postsave_inference_grpo.json),
and
[submission_summary.json](polyguard-rl/docs/results/final_submission_evidence/reports/submission_summary.json).
### SFT vs GRPO by Model

This chart is intentionally transparent about artifact availability. Qwen 0.5B
and 1.5B have SFT reports/histories and post-save SFT evidence in the repo, but
their adapter directories were not present in the local/final artifact mirrors
at packaging time. Qwen 3B has the complete SFT plus GRPO artifact set.
The packaged manifest records Qwen 3B as complete with 125 checkpoint files
(`433,208,536` bytes), 11 SFT adapter files (`30,655,905` bytes), 11 GRPO
adapter files (`30,656,841` bytes), and 9 report files (`5,930,214` bytes).
Qwen 0.5B and 1.5B are retained as report/post-save evidence only.
Manifest:
[docs/results/final_submission_evidence/manifest.json](polyguard-rl/docs/results/final_submission_evidence/manifest.json).
### Product Pipeline vs Basic LLM Proxy

Matched-seed evaluation compares a basic LLM-style first-legal proxy, an
SFT-style safety ranker, and the full PolyGuard orchestrated pipeline. The same
PolyGuard verifier/reward system judges all three.
| Policy | Episodes | Avg reward | Legality rate | Failure/exploit rate | Candidate diversity |
| --- | ---: | ---: | ---: | ---: | ---: |
| Basic LLM proxy | 8 | `0.762` | `1.0` | `0.25` | 1 |
| SFT policy proxy | 8 | `0.818` | `1.0` | `0.0` | 2 |
| Full PolyGuard pipeline | 8 | `0.805` | `1.0` | `0.0` | 2 |
The full pipeline improves average verifier reward over the basic LLM proxy by
`+0.043` while reducing visible failure/exploit rate from `0.25` to `0.0`.

Two matched seeds expose the core failure mode: the basic policy repeatedly
kept a regimen despite the hidden `warfarin_like` + `nsaid_like` DDI holdout,
triggering `holdout_ddi_not_addressed`. The full pipeline selected safer dose
or hold candidates and avoided those failure reasons.
Source:
[basic_llm_vs_polyguard_report.json](polyguard-rl/docs/results/final_submission_evidence/reports/basic_llm_vs_polyguard_report.json).
### Reward Components and Channels


The reward charts are as important as the scalar reward curve. They show
whether the model is improving by becoming safer and more process-faithful or
merely exploiting one easy component. The reports log the full 13-component
reward vector and the four primary channels for GRPO and evaluation runs.
For Qwen 3B GRPO, the tracked average primary channels are:
| Channel | Average |
| --- | ---: |
| `safety_legality` | `0.816` |
| `clinical_improvement` | `0.609` |
| `dosing_quality` | `0.543` |
| `process_integrity` | `0.875` |
### Post-Save Inference

Post-save inference is separate from training. The exported/activated artifact
is loaded and asked to choose candidate ids on held prompt samples. The Qwen 3B
GRPO adapter path produced:
- `model_source: adapter`
- `samples: 5`
- `valid_rate: 1.0`
- `avg_env_reward: 0.726`
- `avg_latency_seconds: 3.681`
The caveat matters: `valid_rate: 1.0` means the output was parseable and
executable as a candidate selection. In the five-sample Qwen 3B post-save GRPO
report, four valid samples still terminated with `exploit_detection`. That is
retained as safety evidence, because PolyGuard's job is to expose suspicious or
loop-like behavior instead of hiding it behind a clean parse metric.
## Agentic Evaluation
Evaluation is not one benchmark number. The evaluation stack under
[app/evaluation/](polyguard-rl/app/evaluation/) includes offline policy
evaluation, safety evaluation, dosing evaluation, robustness under missing labs
and noisy inputs, calibration and abstention evaluation, process fidelity,
subgroup summaries, explainability grounding, baseline comparison, policy
ablations, failure mining, and action traces.
The tracked benchmark report records:
| Metric family | Result |
| --- | --- |
| Offline avg reward | `0.772833` |
| Offline legal rate | `1.0` |
| Severe violation rate | `0.0` |
| Illegal step rate | `0.0` |
| Dosing target attainment | `0.75` |
| Dosing toxicity avoidance | `1.0` |
| Missing-labs safety rate | `0.666667` |
| Noisy-dose, conflicting-meds, alias-noise, hidden-duplicate, wrong-candidate-id, stale-evidence, delayed-ADE safety/resilience | `1.0` |
| Calibration ECE proxy | `0.08625` |
| Process fidelity | `0.92` |
| Explainability grounding | `0.8` |
Source:
[docs/results/benchmark_report.json](polyguard-rl/docs/results/benchmark_report.json).
The improvement gate compares baseline and candidate reports:
| Gate dimension | Delta |
| --- | ---: |
| Average reward | `+0.025833` |
| Legality rate | `0.0` non-regression |
| Success rate | `0.0` non-regression |
| Process fidelity | `+0.92` |
| Timeout rate | `0.0` non-regression |
| Failure visibility | `0.0` non-regression |
Source:
[docs/results/improvement_report.json](polyguard-rl/docs/results/improvement_report.json).
### Policy Ablation Results
| Stack | Avg reward | Legality | Visible failure rate | Exploit detections | Interpretation |
| --- | ---: | ---: | ---: | ---: | --- |
| `bandit_only` | `0.779625` | `1.0` | `0.0625` | 2 | Strong deterministic shortlist behavior with low failure visibility |
| `llm_only` | `0.772391` | `1.0` | `0.3043` | 7 | Legal, but more loop-like failure behavior |
| `llm+bandit` | `0.764739` | `1.0` | `0.3043` | 7 | Current combined stack needs tighter exploration/control in these ablation settings |

The point of these ablations is not to claim every combined policy is always
better. The point is that PolyGuard can localize behavior: legality remains
high, while failure mining shows whether a stack is looping, over-reviewing,
or selecting non-improving candidates.
Source:
[policy_ablation_report.json](polyguard-rl/docs/results/final_submission_evidence/reports/policy_ablation_report.json).
## OpenEnv and Product Surfaces
The OpenEnv package is compact:
```yaml
spec_version: 1
name: polyguard-openenv
runtime: fastapi
app: app.env.fastapi_app:app
port: 8100
```
The OpenEnv runtime exposes `POST /reset`, `POST /step`, `GET /state`,
`GET /metadata`, `GET /schema`, `POST /mcp`, `GET /health`, `GET /ws`, and
backward-compatible `/env/*` routes.
The product API in [app/api/routes.py](polyguard-rl/app/api/routes.py) wraps
the environment, orchestrator, policy runtime, evaluation, evidence search,
cases, metrics, and medication-alternative tooling. Product-facing endpoints
include `/env/reset`, `/env/step_candidate`, `/agents/orchestrate`,
`/policy/infer`, `/policy/model_status`, `/eval/run_policy`,
`/metrics/training`, `/evidence/query`, and `/tools/medication_alternatives`.

## Operations and Deployment
The repository keeps deployment and artifact operations explicit:
| Surface | Files |
| --- | --- |
| Local/container runtime | [Dockerfile](polyguard-rl/Dockerfile), [Dockerfile.space](polyguard-rl/Dockerfile.space), [docker-compose.yml](polyguard-rl/docker-compose.yml), [requirements.txt](polyguard-rl/requirements.txt), [requirements-space.txt](polyguard-rl/requirements-space.txt) |
| Product Space/API deployment | [scripts/deploy_space.sh](polyguard-rl/scripts/deploy_space.sh), [scripts/deploy_space_api.py](polyguard-rl/scripts/deploy_space_api.py), [docs/deployment.md](polyguard-rl/docs/deployment.md) |
| Training and evidence Spaces | [scripts/deploy_training_space.py](polyguard-rl/scripts/deploy_training_space.py), [scripts/monitor_training_space_status.py](polyguard-rl/scripts/monitor_training_space_status.py), [app/hf_space/training_runner.py](polyguard-rl/app/hf_space/training_runner.py), [app/hf_space/evidence_runner.py](polyguard-rl/app/hf_space/evidence_runner.py) |
| Artifact packaging and activation | [scripts/deploy_final_artifact_space.py](polyguard-rl/scripts/deploy_final_artifact_space.py), [scripts/package_active_model_bundle.py](polyguard-rl/scripts/package_active_model_bundle.py), [scripts/install_hf_active_bundle.py](polyguard-rl/scripts/install_hf_active_bundle.py), [docs/results/active_model_manifest.json](polyguard-rl/docs/results/active_model_manifest.json) |
| Submission validation | [scripts/acceptance_gate.py](polyguard-rl/scripts/acceptance_gate.py), [scripts/validate_submission_links.py](polyguard-rl/scripts/validate_submission_links.py), [docs/submission_checklist.md](polyguard-rl/docs/submission_checklist.md), [docs/submission_artifacts.md](polyguard-rl/docs/submission_artifacts.md) |
The important operational distinction is that local smoke artifacts, remote
training-space logs, final artifact packaging, and active-model installation
are separate stages. Final claims are tied to the curated evidence bundle, not
to whichever intermediate output directory happens to exist in a checkout.
## The Workbench UI
The UI is a React 18 + Vite + TypeScript workbench under
[app/ui/frontend/](polyguard-rl/app/ui/frontend/). It is not the environment
itself; it is an operator surface over the API and OpenEnv runtime.
[Live workbench Space](https://huggingface.co/spaces/TheJackBright/polyguard-openenv-workbench)

The main views cover patient workbench, episode replay, policy comparison and
policy lab, precision dosing, training monitor, safety inspector, candidate
actions, reward panel, episode trace, and alternative medication search through
`/tools/medication_alternatives`.
The Patient Workbench shows the active model chip, current scenario, candidate
set, agent-vs-environment flow, reward breakdown, and action trace without
requiring the reader to inspect raw JSON. The UI is intentionally a workbench,
not a polished clinical application.
### UI Sequence
The five UI screenshots are checked in under `polyguard-rl/docs/UI Images/`.
1. The workbench opens with model truth, live episode context, scenario status,
candidate count, and reward state.

2. The episode panel makes the patient, task, difficulty, sub-environment, risk
delta, and candidate-action console visible without reading raw JSON.

3. Candidate selection is paired with reward-channel feedback, current
medications, and blocked/available action visibility.

4. After an action, the workbench exposes history, warnings, decision payload,
grounded facts, explanation, evidence, and event logs.

5. The alternatives tool surfaces medication substitutions from the current
regimen and links out to source labels.

## Demo Videos
### [UI Walkthrough Video](https://drive.google.com/file/d/1YOzad5gvx-tSmGzJNuBgokBF4-dX2T2H/view?usp=sharing)
This walkthrough shows the deployed workbench surface, including the live model
chip, episode context, candidate actions, reward panels, and evidence-oriented
patient review flow.
### [Agent In Action: Action Button Demo](https://drive.google.com/file/d/1eHk1v0OYJRrLWVO97ZclN05MYHxmNnmc/view?usp=sharing)
This demo focuses on what the action button does: selecting a candidate,
submitting it through the environment, producing a verifier-scored transition,
and exposing the resulting reward, action history, warnings, and explanation.
### [World Model Tool: Tavily and OpenFDA Alternative Suggestions](https://drive.google.com/file/d/1GaUyyaXaBCHjhHFbpkprojNt5pLNAoYi/view?usp=sharing)
This tool demo shows the world-model support path for alternative medication
suggestions, using Tavily and the OpenFDA government database to retrieve
candidate alternatives and side-effect evidence for safer review.
## How a Reviewer Should Read the Repository
For a fresh reviewer, the intended path is:
1. Read the artifact index:
[polyguard-rl/docs/submission_artifacts.md](polyguard-rl/docs/submission_artifacts.md).
2. Inspect the final curated evidence:
[polyguard-rl/docs/results/final_submission_evidence/README.md](polyguard-rl/docs/results/final_submission_evidence/README.md).
3. Open the one-run notebook:
[PolyGuard_SFT_GRPO_One_Run_Runner.ipynb](polyguard-rl/PolyGuard_SFT_GRPO_One_Run_Runner.ipynb).
4. For local smoke work, follow [docs/training.md](polyguard-rl/docs/training.md)
and the local scripts
[scripts/run_env_local.sh](polyguard-rl/scripts/run_env_local.sh),
[scripts/run_api_local.sh](polyguard-rl/scripts/run_api_local.sh), and
[scripts/run_ui_local.sh](polyguard-rl/scripts/run_ui_local.sh).
5. For full training/reproduction, use the notebook or training docs rather
than copying private artifact commands out of old drafts.
6. For final public artifacts, use the final artifact Space:
[adithya9903/polyguard-openenv-final-artifacts](https://huggingface.co/spaces/adithya9903/polyguard-openenv-final-artifacts).
## Evidence and Artifact Inventory
Important evidence paths:
- Final overview:
[docs/results/final_submission_evidence/README.md](polyguard-rl/docs/results/final_submission_evidence/README.md)
- Artifact manifest:
[docs/results/final_submission_evidence/manifest.json](polyguard-rl/docs/results/final_submission_evidence/manifest.json)
- Three-model summary:
[docs/results/final_submission_evidence/reports/submission_summary.json](polyguard-rl/docs/results/final_submission_evidence/reports/submission_summary.json)
- Qwen 3B GRPO report:
[docs/results/final_submission_evidence/reports/grpo_trl_run.json](polyguard-rl/docs/results/final_submission_evidence/reports/grpo_trl_run.json)
- Post-save GRPO inference:
[docs/results/final_submission_evidence/reports/postsave_inference_grpo.json](polyguard-rl/docs/results/final_submission_evidence/reports/postsave_inference_grpo.json)
- Basic LLM vs PolyGuard:
[docs/results/final_submission_evidence/reports/basic_llm_vs_polyguard_report.json](polyguard-rl/docs/results/final_submission_evidence/reports/basic_llm_vs_polyguard_report.json)
- Policy ablation:
[docs/results/final_submission_evidence/reports/policy_ablation_report.json](polyguard-rl/docs/results/final_submission_evidence/reports/policy_ablation_report.json)
- Action traces:
[docs/results/final_submission_evidence/reports/action_traces.jsonl](polyguard-rl/docs/results/final_submission_evidence/reports/action_traces.jsonl)
- Curated charts:
[docs/results/final_submission_evidence/charts/curated/README.md](polyguard-rl/docs/results/final_submission_evidence/charts/curated/README.md)
Important tests:
| Category | Tests |
| --- | --- |
| Environment contract | [tests/test_openenv_contract.py](polyguard-rl/tests/test_openenv_contract.py), [tests/test_env_reset.py](polyguard-rl/tests/test_env_reset.py), [tests/test_env_step.py](polyguard-rl/tests/test_env_step.py), [tests/test_env_step_flow.py](polyguard-rl/tests/test_env_step_flow.py), [tests/test_future_subenvs.py](polyguard-rl/tests/test_future_subenvs.py) |
| Reward and safety | [tests/test_reward_functions.py](polyguard-rl/tests/test_reward_functions.py), [tests/test_reward_range.py](polyguard-rl/tests/test_reward_range.py), [tests/test_reward_channels.py](polyguard-rl/tests/test_reward_channels.py), [tests/test_anti_cheat.py](polyguard-rl/tests/test_anti_cheat.py), [tests/test_constraints.py](polyguard-rl/tests/test_constraints.py), [tests/test_timeout_logic.py](polyguard-rl/tests/test_timeout_logic.py) |
| Policy and runtime | [tests/test_agents.py](polyguard-rl/tests/test_agents.py), [tests/test_contextual_bandit.py](polyguard-rl/tests/test_contextual_bandit.py), [tests/test_policy_schema.py](polyguard-rl/tests/test_policy_schema.py), [tests/test_provider_runtime.py](polyguard-rl/tests/test_provider_runtime.py), [tests/test_postsave_inference.py](polyguard-rl/tests/test_postsave_inference.py), [tests/test_checkpoint_integrity.py](polyguard-rl/tests/test_checkpoint_integrity.py) |
| API and product tooling | [tests/test_api.py](polyguard-rl/tests/test_api.py), [tests/test_medication_alternatives.py](polyguard-rl/tests/test_medication_alternatives.py), [tests/test_remote_env.py](polyguard-rl/tests/test_remote_env.py) |
| Data and evidence | [tests/test_parser.py](polyguard-rl/tests/test_parser.py), [tests/test_dataops_parser.py](polyguard-rl/tests/test_dataops_parser.py), [tests/test_graph_infer.py](polyguard-rl/tests/test_graph_infer.py), [tests/test_submission_evidence.py](polyguard-rl/tests/test_submission_evidence.py) |
| Submission, notebook, and HF flow | [tests/test_acceptance_gate.py](polyguard-rl/tests/test_acceptance_gate.py), [tests/test_runner_notebook.py](polyguard-rl/tests/test_runner_notebook.py), [tests/test_hf_training_sweep.py](polyguard-rl/tests/test_hf_training_sweep.py) |
Additional architecture diagrams:
- [System architecture](polyguard-rl/docs/assets/diagrams/system_architecture.png)
- [Runtime step flow](polyguard-rl/docs/assets/diagrams/runtime_step_flow.png)
- [Data and training pipeline](polyguard-rl/docs/assets/diagrams/data_training_pipeline.png)
- [Multi-agent orchestration](polyguard-rl/docs/assets/diagrams/multi_agent_orchestration.png)
- [Reward decomposition](polyguard-rl/docs/assets/diagrams/reward_decomposition.png)
- [Episode state machine](polyguard-rl/docs/assets/diagrams/episode_state_machine.png)
- [Evidence generation flow](polyguard-rl/docs/assets/diagrams/evidence_generation_flow.png)
- [Deployment topology](polyguard-rl/docs/assets/diagrams/deployment_topology.png)
- [Frontend runtime surface](polyguard-rl/docs/assets/diagrams/frontend_runtime_surface.png)
## Limitations
PolyGuard is a simulator and research environment. Its current data substrate
is compact and intentionally inspectable, not a production clinical knowledge
base. The final evidence set is strongest for Qwen 3B because that run has
complete SFT, GRPO, post-save GRPO, policy-ablation, adapter, and checkpoint
evidence. Qwen 0.5B and 1.5B have SFT reports/histories and post-save SFT
evidence, but their adapter directories are marked `reports_only_or_partial` in
the final manifest.
The reward model is hand-designed and auditable. That is a feature for this
OpenEnv setting, but it also means reward-channel design should be
stress-tested as the data grows. The current ablations show that contextual
bandits are useful and inspectable, while the `llm+bandit` combined stack needs
more tuning to avoid loop-like failure behavior in some settings.
The right conclusion is not "this is a clinical decision system." The right
conclusion is that constrained environment feedback, verifier-backed rewards,
agentic evaluation, and explicit failure mining are a better substrate for
safety-critical medication-policy learning than free-form prompt responses.
## References
- Alexandre Larouche, Audrey Durand, Richard Khoury, Caroline Sirois.
[Neural Bandits for Data Mining: Searching for Dangerous Polypharmacy](https://arxiv.org/abs/2212.05190).
arXiv:2212.05190.
- World Health Organization.
[Medication Without Harm](https://www.who.int/initiatives/medication-without-harm).
- CDC.
[FastStats: Medication Safety Data](https://www.cdc.gov/medication-safety/data-research/facts-stats/index.html).
- Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS.
[US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014](https://jamanetwork.com/journals/jama/fullarticle/2585977).
JAMA. 2016;316(20):2115-2125.
- AHRQ / NCBI Bookshelf.
[Deprescribing To Reduce Medication Harms in Older Adults](https://www.ncbi.nlm.nih.gov/books/NBK600387/).
- American Geriatrics Society.
[2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults](https://pmc.ncbi.nlm.nih.gov/articles/PMC12478568/).
- O'Mahony et al.
[STOPP/START criteria for potentially inappropriate prescribing in older people: version 3](https://pmc.ncbi.nlm.nih.gov/articles/PMC10447584/).
## License
The project package declares an MIT license in
[polyguard-rl/pyproject.toml](polyguard-rl/pyproject.toml). See
[polyguard-rl/LICENSE](polyguard-rl/LICENSE) for the license text.
|